Vitrase hyaluronidase enzyme formulation regulatory update

The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will review on March 17 ISTA's NDA for its Vitrase ovine hyaluronidase to treat vitreous hemorrhage. Last year, ISTA said that Vitrase fa...